Superdisintegrants Market Scope And Analysis

  • Report Code : TIPRE00004423
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Superdisintegrants Market Analysis, Scope, and Growth by 2031

Buy Now

Superdisintegrants Market Report Superdisintegrants Market Size and Share Superdisintegrants Market Scope and Analysis

Superdisintegrants Market Report Scope

Report Attribute Details
Market size in 2023 US$ 0.50 Billion
Market Size by 2031 US$ 0.89 Billion
Global CAGR (2023 - 2031) 7.60%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Synthetic Superdisintegrants
  • Natural Superdisintegrants
  • Other Superdisintegrants
By Formulation
  • Tablets
  • Capsules
By Therapeutic Area
  • Neurological Diseases
  • Gastrointestinal Diseases
  • Oncology
  • Inflammatory Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Other Diseases
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Ashland
  • Asahi Kasei Corporation
  • Avantor Inc
  • BASF SE
  • Corel Pharma Chem
  • Dow DuPont Inc
  • DFE Pharma
  • JRS Pharma
  • MERCK KGAA
    		•

    Superdisintegrants Market News and Recent Developments

    The superdisintegrants market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the superdisintegrants market are listed below:

    • KalVista Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced positive phase 1 data for an orally disintegrating tablet (ODT) formulation for its lead compound sebetralstat. Sebetralstat is currently being developed in the phase 3 KONFIDENT clinical trial as a potential on-demand treatment for hereditary angioedema (HAE) attacks. (Source: KalVista Pharmaceuticals, Inc., Press Release, October 2022)
    • Ingredion announced two strategic investments in India to expand into high-value pharma applications. During the third quarter of 2022, the company acquired Amishi Drugs & Chemicals (AD&C), headquartered in Ahmedabad, India, which manufactures super disintegrants, lubricants, and viscosifiers complementing its portfolio of starch, mannitol, and dextrose product offerings. (Source: Ingredion, News Latter, March 2023)

     Superdisintegrants Market Report Coverage and Deliverables

    The “Superdisintegrants Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Superdisintegrants market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Superdisintegrants market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Superdisintegrants market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the superdisintegrants market
    • Detailed company profiles